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Crk adaptor proteins are key players in signal transduction from a variety of cell surface
receptors. They are involved in early steps of lymphocyte activation through their SH2-
mediated transient interaction with signal transducing effector molecules, such as Cbl,
ZAP-70, CasL, and STAT5. In addition, they constitutively associate, via their SH3 domain,
with effector molecules, such as C3G, that mediate cell adhesion and regulate lymphocyte
extravasation and recruitment to sites of inflammation. Recent studies demonstrated that
the conformation and function of CrkII is subjected to a regulation by immunophilins,
which also affect CrkII-dependent T-cell adhesion to fibronectin and migration toward
chemokines. This article addresses mechanisms that regulate CrkII conformation and
function, in general, and emphasizes the role of Crk proteins in receptor-coupled
signaling pathways that control T-lymphocyte adhesion and migration to inflammatory
sites.
Keywords: Crk adaptor proteins, signal transduction, T lymphocytes, cell adhesion, cell migration, immunophilins,
cyclophilin A, cyclosporin A
Introduction
Adaptor proteins are essential components of signal transduction pathways in all cell types
due to their ability to link engaged receptors to specific downstream signaling cascades.
The presence of multiple protein–protein interaction domains in an adaptor protein enables
the simultaneous interaction with two or more effector molecules and the spatially and
temporally orchestrated assembly of multimolecular complexes that are essential for signal
transduction.
The mammalian CT10 (chicken tumor virus number 10) regulator of kinase (Crk) adaptor
proteins, CrkI and CrkII, are alternatively spliced products of a single gene (1). Both proteins include
an N-terminal Src homology 2 (SH2) domain followed by a C-terminal SH3 domain (2–4). CrkII
includes an additional SH3 domain at the C-terminus (SH3C), which is separated from the SH3N
by a 47-residue-containing spacer region. A third member of the family, termed Crk-like (CrkL),
is encoded by a closely related gene and possesses an overall structure similar to that of CrkII
(2–4).
The Crk proteins are ubiquitously expressed and act as major convergence points of tyrosine
kinase signaling pathways. They utilize their SH2 and SH3 domains for interaction with multiple
effector molecules and integrate molecular information obtained from diverse sources, such as
growth factors, extracellular matrix (ECM), pathogens, and apoptotic cells (2–6). In general, Crk
proteins play an essential role in the regulation of immune cell functions leading to cell adhesion
and migration, proliferation, differentiation, and apoptosis (2–6).
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The Structure and Binding Partners of Crk
Crk proteins possess two types of basic modules that function
as protein–protein interaction domains. The Crk amino-terminus
SH2 domain binds tyrosine-phosphorylated proteins containing
the preferred consensus motif, pY-x-x-P, whereby specificity is
provided by the two to five residues C-terminal of the phospho-
tyrosyl group (7) (Figure 1). In accordance, Crk proteins interact
via their SH2 domain with a large number of T-lymphocyte effec-
tor proteins, including the Crk-associated substrate lymphocyte
type [p105CasL, also known as human enhancer of filamentation
protein 1 (HEF1) or NEDD9] (8), Casitas B-lineage lymphoma (c-
Cbl) (9, 10), and ζ-chain-associated protein kinase 70kDa (ZAP-
70) (11, 12) (Figure 2).
A second module found in all Crk proteins is an SH3 domain,
which binds polyproline-rich sequences, with a preference toward
FIGURE 1 | Schematic structure and mode of regulation of CrkII. The
CrkII protein contains two protein–protein interaction domains and a single
regulatory domain. The N-terminal CrkII-SH2 domain (red) transiently interacts
with phosphorylated tyrosine-containing peptide sequences possessing a
pY-x-x-P consensus motif, which is found in signaling proteins, such as
tyrosine-phosphorylated Cbl and ZAP-70. The CrkII-SH3N domain (green)
interacts with polyproline-rich sequences in proteins such as C3G and HPK1,
with a preference toward the P-x-L-P-x-K motif. The CrkII-SH3C (light blue) is
an atypical SH3 domain due to the presence of hydrophobic, instead of
aromatic, residues in its polyproline binding pocket, which reduces its affinity
to polyproline-containing peptides. It functions predominantly as a regulatory
region, which under certain conditions can block ligand interaction with CrkII.
A 47-residue-containing spacer region, which links the two SH3 domains,
contains a tyrosine residue (Tyr 221) that is a target for phosphorylation by
Abl, in ligand-stimulated cells. Phospho-Tyr221 can intramolecularly interact
with, and block the SH2 domain, and induce a conformational change that
alters CrkII accessibility to other potential ligands. A second motif in the linker
region is a substrate for the peptidyl-prolyl cis–trans isomerases (PPIases),
such as cyclophilin A and FK506, which can catalyze the cis–trans
isomerization of the Gly-Pro220 peptide bond and interconverts CrkII between
two distinct conformations. The CrkII cis isomer adopts a closed,
autoinhibited conformation, while the CrkII trans isomer adopts an open,
uninhibited conformation, which is available for interaction with SH2 and SH3
binding partners. Blue arrows indicate sites of interaction and a red arrow
indicates a site of phosphorylation. Abl, Abelson murine leukemia viral
oncogene; C3G, Cbl, Casitas B-lineage lymphoma; CRK, SH3
domain-binding guanine nucleotide-releasing factor; Crk, CT10 (chicken
tumor virus number 10) regulator of kinase; CypA, cyclophilin A; FKBP, FK506
binding protein; GPY, Gly-Pro-Tyr motif; HPK1, hematopoietic progenitor
kinase 1; Lck, lymphocyte-specific protein tyrosine kinase; pY,
phosphotyrosine; SH2, Src homology 2; SH3C, C-terminal Src homology
domain 3; SH3N, N-terminal Src homology domain 3; PPIase, peptidyl-prolyl
cis–trans isomerase; SHP1, SH2 domain-containing protein tyrosine
phosphatase 1; SHP2, SH2 domain-containing protein tyrosine phosphatase
2; Y, tyrosine residue; ZAP-70, zeta-chain-associated protein kinase 70.
the P-x-L-P-x-K motif (17) (Figure 1). In T cells, this domain
interacts with proteins such as the Crk SH3N domain-binding
guanine nucleotide-releasing factor (C3G) (9, 18) and the
hematopoietic progenitor kinase 1 (HPK1) (19, 20) (Figure 2).
It has been suggested that the CrkI/II- and CrkL-SH3N domains
exhibit redundant substrate specificity and constitutively interact
with their ligands, independent of the cell activation state (21, 22).
Both SH2 and SH3 domains of CrkII interact with multiple bind-
ing partners in different cell types (2–6), although information
about such interactions in T cells is relatively limited.
The SH3C of both CrkII and CrkL possesses a consensus
SH3 sequence homology, but its binding surface contains some
hydrophobic residues that substantially reduce its affinity to
polyproline-rich sequences (23). Two independent studies have
indicated that the Crk-SH3C domain contains a nuclear export
signal that interacts with the Crm1/Exportin (24, 25). However,
the physiological relevance of this low-affinity interaction has yet
to be determined.
More recent studies suggested that the main function of the
SH3C domain is directed at stabilizing CrkII and/or CrkL in a
conformation that negatively regulates their biological function
(25–29).
Conformation, Function, and Expression
Regulation of Crk Adaptor Proteins
Apart from the SH2 and SH3 domains, Crk proteins contain
additional regulatory motifs that may have an impact on the
protein conformation and biological activity (Figure 1). One such
motif includes a tyrosine residue within the linker region teth-
ering the two SH3 domains (Tyr221 and Tyr207 in the human
CrkII and CrkL, respectively) (30, 31). This tyrosine undergoes
phosphorylation by a protein tyrosine kinase (PTK), such as Abl,
following the interaction of a number of different ligands with
their cognate cell surface receptors (31, 32). In addition, Tyr207
in CrkL is intensely phosphorylated by the oncogenic tyrosine
kinase Bcr-Abl in Philadelphia chromosome-positive leukemia
(30, 32), where CrkL is required for the Bcr-Abl-induced cell
transformation (33).
The conserved tyrosine residues in CrkII and CrkL reside
within a Y-x-x-P sequence, and upon phosphorylation, they inter-
nally interact with the SH2 domain, thus operating as dominant-
negative binding motifs (32). NMR spectrometry analysis con-
firmed that phospho-Tyr221 in CrkII does indeed interact with
the adjacent CrkII-SH2 domain and alters the protein’s structure
(34). The ensuing conformational change is expected to block
the SH3N, in addition to the SH2 domain, releasing CrkII from
its binding partners and repressing CrkII-mediated signaling (32,
34).
A second regulatory motif within an extended loop in the SH2
domain possesses a proline-rich region, which is dispensable for
phosphopeptide binding and is able to interact with various SH3
domains, including that of the Abl PTK (32, 35, 36). Although
the in vitro interaction of the full-length non-phosphorylated
CrkII with Abl SH3 domain was rather weak, phosphorylation
of CrkII-Tyr221, or addition of a phosphopeptide correspond-
ing to the CrkII-Tyr221 phosphorylation site, stimulated CrkII
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FIGURE 2 | Involvement of Crk adaptor proteins in TCR- and integrin-coupled signaling pathways that regulate T-lymphocyte adhesion. A simplified
scheme of surface receptors and signaling pathways that regulate T-cell activation and adhesion. T-cell receptor (TCR) ligation results in Lck-mediated tyrosine
phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) on the intracellular portion of the CD3 subunits, leading to the recruitment of
ζ-chain-associated protein kinase of 70 kDa (ZAP-70) and its phosphorylation on several distinct tyrosine residues, including Tyr315 (13). The subsequent Lck- and
ZAP-70-mediated tyrosine phosphorylation of multiple substrates activates several signaling cascades, in which calcineurin (CaN) and protein kinase C theta (PKCθ)
play a major role, leading to cell activation, proliferation, and differentiation. In parallel, Crk adaptor proteins transiently interact via their SH2 domain with ZAP-70
Tyr315 and, apparently, promote the recruitment of additional Crk-binding proteins to the receptor site that contribute to the “outside-in” signaling pathway (11). Crk
interaction with the guanine nucleotide-exchange factor (GEF), C3G, imposes the conversion of the small GTPase, RAP1, to an active GTP-bound protein, which in
turn leads to activation of the LFA-1 integrin and increases T-cell adhesion. Activation of this “inside-out” signaling pathway, which promotes integrin-mediated T-cell
adhesion, is sensitive to a regulation by immunophilins (14). GEF-mediated activation of Rap1, which is essential for upregulation of the integrin receptors, can also
be mediated by a WASP family verprolin-homologous protein-2 (WAVE2)-regulated CrkL-C3G complexes (15) as well as by other Crk-independent pathways (16).
Integrins can also initiate “outside-in” and “inside-out” signaling pathways since their interaction with ICAM-1 or extracellular matrix results in signal delivery that
promotes conformational changes in adjacent integrins leading to increase in their clustering and binding affinity. For simplicity, additional effector proteins that
interact with Crk, such as WAVE and immunophilins, which are also involved in the regulation of T-cell adhesion, are not included in the figure. Red arrows indicate
direct effects and black arrows indicate indirect effects. Ag, antigen; AP-1, activation protein-1; C3G, CRK SH3 domain-binding guanine nucleotide-releasing factor;
CaN, calcineurin; Cas, Crk-associated substrate; CasL, Cas lymphocyte type; Crk, CT10 (chicken tumor virus number 10) regulator of kinase; GDP, guanosine
diphosphate; GTP, guanosine-50-triphosphate; Lck, lymphocyte-specific protein tyrosine kinase; NF-AT, nuclear factor of activated T cells; NF-κB, nuclear factor
kappa-light-chain-enhancer of activated B cells; P, a site of tyrosine phosphorylation; PKCθ, protein kinase C theta; PLCγ1, phospholipase C gamma 1; Rac,
Ras-related C3 botulinum toxin substrate; Rap, Ras-related protein; Ras, rat sarcoma; ZAP-70, zeta-chain-associated protein kinase 70.
association with the Abl SH3 domain. The results suggested that
the proline-rich insert within the Crk SH2 domain constitutes an
SH3 domain-bindingmotif which is regulated by phosphopeptide
ligand binding to the Crk SH2 domain. CrkI possesses an identical
SH3N domain allowing it to associate with Abl, but due to the
lack of the linker region that includes Tyr221 (in addition to
the entire SH3C domain), it cannot undergo phosphorylation
in vivo, and apparently exhibits a very low affinity to the Abl SH3
domain.
Recent studies revealed an additional regulatory motif within
the linker region of the chicken, but not human, CrkII, which
serves as a target for peptidyl-prolyl cis–trans isomerases (PPI-
ases) (28, 29, 37, 38). Interconversion between the cis and trans
isomers of the chickenCrkII occurred at theGly237-Pro238 prolyl
bond and was catalyzed by the PPIase, cyclophilin A (CypA).
Acquisition of a cis conformation resulted in an intramolecular
interaction between the two SH3 domains of CrkII, forming a
closed conformation of an autoinhibited molecule. In contrast,
the CrkII trans conformer acquired a relatively open and extended
conformation that was readily available for interaction with SH2-
and SH3N-binding partners. PPIases catalyze both cis-to-trans
and trans-to-cis interconversion of CrkII, thereby determining
the temporal and spatial activation of CrkII and CrkII-regulated
signaling events.
More recent studies demonstrated that human T-cell-derived
CrkII, but not CrkI, can physically interact with representatives
of two families of PPIases, CypA and FK506 binding protein
(FKBP), collectively termed immunophilins (14). In vitro coin-
cubation of CypA with human T-cell-derived CrkII increased
CrkII binding to C3G while immunophilin inhibitors [such as
cyclosporine A (CsA) and FK506] downregulated CrkII binding
to C3G, suggesting that CrkII-C3G interaction may be subjected
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to a regulation by immunophilins (14). This assumption was sup-
ported by fluorescence resonance energy transfer (FRET) studies
of Jurkat T cells transfected with PICCHUx, a chimeric plas-
mid encoding the human CrkII1-236 sandwiched between cyan
fluorescent protein (CFP) and yellow fluorescent protein (YFP).
The basal FRET level of these cells was further augmented by
CsA and FK506 treatment, reflecting a drug-induced inhibition
of immunophilins and a trans-to-cis conversion of CrkII.
The differential sensitivity of the truncated chicken vs. human
CrkII to PPIases was attributed to the nature of the amino acid that
immediately follows the Pro238 (chicken)/237 (human) residue,
Phe and Ile in the chicken and the human CrkII, respectively
(28, 29, 38). Since PICCHUx encodes a truncated human CrkII,
which lacks Pro237, we predict that the Gly219-Pro220 motif
plus its adjacent Tyr221 residue (an aromatic amino acid that
is structurally related to Phe, except for a singly extra hydroxyl
group) may be the site of immunophilin-mediated isomerization
of the human CrkII.
CrkII shares with CrkL a high degree of sequence homology
and ligand-binding preference, but the two proteins have dis-
tinct physiological roles. Structural studies demonstrated that the
two proteins exhibit a distinct intramolecular assembly of their
domains (39, 40), which might explain the differences in their
biological activities. Furthermore, CrkL, unlike CrkII, lacks an
immunophilin substrate motif.
Another line of studies demonstrated that the extent of expres-
sion of Crk is subjected to a regulation by microRNA (miRNA)
(41). These studies were based on bioinformatic analyses pre-
dicting that Crk can be directly targeted by miR-126. Indeed,
analysis performed in HSC-T6 cells (an immortalized rat liver
stellate cell line) revealed that the Crk 30UTR is a direct target for
miR-126. Furthermore, miR-126 overexpression led to decreased
Crk protein expression, suggesting that Crk function and Crk-
dependent signaling pathways may also be regulated at the Crk
protein expression level.
Crk-Mediated Regulation of T-Cell
Adhesion and Motility
The ability of T lymphocytes to physically interact with antigen-
presenting cells (APCs) and adhere to vascular endothelial cells
is absolutely essential for the induction of all types of T-cell-
mediated immune responses. Accordingly, deficiency in adhesion
molecules and/or their signaling pathways, such as in leuko-
cyte adhesion deficiency (LAD), results in impaired or com-
plete absence of immune responses (42). Interaction of T cells
with APCs is a prerequisite for antigen recognition by the T-
cell antigen receptor (TCR) and the subsequent activation and
differentiation of the T cells into functional effector cells (43).
In addition, migration of T cells to sites of inflammation is
dependent on their ability to adhere to endothelial cells as the
first step of extravasation and subsequent migration (44). Adhe-
sion of T cells is mediated by members of the integrin family
of receptors, such as lymphocyte function-associated antigen 1
(LFA-1; CD11a/CD18) and very late antigen-4 (VLA-4, α4β1-
integrin), and additional receptors, such as -selectins, CD44, and
CD31 (44).
A large number of T-cell effector molecules play a role in
the transduction of signals regulating the activity of adhesion
receptors (15, 45–47). C3G is the first protein identified as being
associated with Crk in a constitutive manner and is involved
in cell adhesion (48, 49). It catalyzes guanosine-50-triphosphate
(GTP) exchange by the small G-protein that removes GDP from
small GTPases, such as Rap-1, Rap-2, and R-Ras, allowing their
spontaneous reloading with GTP (50). These findings were ini-
tially observed in fibroblasts or epithelial cells and later on con-
firmed in other cell types, including lymphocytes. The targets
of Rap-1 have been implicated in cell proliferation, cytoskele-
tal reorganization, and cell-to-cell contact (50–52). One of the
most important biological effects of the Crk-C3G-Rap1 signaling
pathway is the regulation of integrins, which mediate adherence
of hematopoietic cells to ECM and stromal cells. The recruit-
ment of C3G to Crk and subsequent loading of Rap1 with GTP
increases the affinity of β1-integrins to the ECM (51, 53). This
CrkL–C3G complex is required for a TCR-coupled signaling
pathway, which involves the WASP family verprolin-homologous
protein-2 (WAVE2) protein and delivers signals that activate
Rap1, regulate both clustering and affinity maturation of inte-
grins, and promote integrin-dependent cell adhesion (15). In
addition, overexpressed CrkL was found to increase cell adhesion
to fibronectin, a process that requires a functional CrkL-SH3N
domain (54, 55).
The CasL docking protein (56) is linked to the β1-integrin
signaling which provides a costimulus for TCR/CD3-driven T-cell
proliferation (57). T cells expressing low levels of CasL exhibited
impaired β1-integrin-mediated costimulation, a defect that was
restored by cell transfection of CasL (58). In TCR-activated T
cells, CasL undergoes tyrosine phosphorylation at multiple Y-D-
x-P motifs, which serve high-affinity docking sites for Crk-SH2
domains (8, 47, 58). The CasL–Crk complex, in turn, recruits
the guanine nucleotide exchange factor (GEF), C3G, which effec-
tively catalyzes the guanine nucleotide exchange reaction for
Rap1 (21).
The important role of Crk in coordinating C3G-CasL-Rap1 sig-
nals leading to integrin-dependent T-cell adhesion and migration
was further substantiated by analysis of T cells from Crk and CrkL
gene conditional knockout mice (21). These T cells were impaired
in their ability to activate Rap1 and responded to chemokines by
increased adhesion and migration to sites of inflammation.
While studies on lymphocytes emphasized the role of Crk in
the regulation of the C3G-dependent activation of Rap1, other
studies demonstrated that Crk regulates additional Rho family
GTPases (59–61) and involved in the regulation of cell migration
by coordinating stimulus-dependent reorganization of the actin
cytoskeleton (61, 62).
Recent studies demonstrated that the Abl kinases, as well as
the CasL and Hef1-associated signal transducer in hematopoietic
cells (Chat-H), are integral components of the signaling path-
way that promotes Rap1 activation and chemokine-induced T-
cell migration (63, 64). Abl kinases, Abl and Arg, are known
to be activated in response to TCR engagement and contribute
to maximal TCR signaling (65). In addition, they are activated
downstream of the SDF-1α chemokine receptor and control the
tyrosine phosphorylation of CasL, an upstream regulator of Rap1
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(63). Thus, by coupling the regulation of CasL and Rap1 effec-
tor proteins to chemokine receptors, the Abl/Arg kinases link
chemokine signals to T-cell polarization and migration. In agree-
ment with the above findings, loss of Abl and Arg in mouse T cells
inhibited their homeostaticmigration and ability to recruit to sites
of inflammation (63).
The Chat-H is a member of the novel SH2-containing protein
(NSP) family (66), also known as the hematopoietic organ-specific
NSP3 isoform. It operates upstream of Rap1 and is required
for both basal and chemokine-induced phosphorylation of
CasL. Chat-H-depleted T cells exhibited diminished chemokine-
induced activation of Rap1 that coincided with impaired integrin-
mediated adhesion and migration. It is therefore assumed that
the effector function of Chat-H involves the coupling of the
chemokine receptor signaling pathways to integrin-mediated T-
cell adhesion (64).
The ZAP-70 PTK is a Crk-binding protein that critically
involved in TCR signaling and also regulates integrin recep-
tor function (67–71). TCR stimulation of ZAP-70-negative T
cells failed to induce β1-integrin-dependent T-cell adhesion to
fibronectin, a defect that was corrected by the reintroduction of
ZAP-70 to the cells (67). In addition, TCR activation-dependent
binding of the lymphocyte function-associated antigen 1 (LFA-1)
integrin to its ligand, intercellular adhesion molecule 1 (ICAM-
1), initiates the delivery of “inside-out” signals to the LFA-1 in a
ZAP-70-dependent manner (69). In these studies, overexpression
of a dominant-negative ZAP-70 in a T-cell hybridoma blocked
the LFA-1-dependent in vitro invasion of the hybridoma cells,
inhibited their ability to disseminate in vivo and form remote
metastases, and suppressed their ability to migrate toward the
chemokine, stromal cell-derived factor 1 (SDF-1) (69). ZAP-70
associates both with the TCR and LFA-1 receptors (68, 70, 72)
and is essential for the delivery of “outside-in” and “inside-out”
signals leading, among other things, to T-cell adhesion. Since
Crk proteins interact with tyrosine phosphorylated and activated
ZAP-70 in a T-cell activation-dependent manner (11, 12, 73), the
physical interaction of ZAP-70 with Crk might be required for
the coupling of ZAP-70 to effector molecules operating down-
stream of activated TCR and/or integrin receptors. In such a case,
TCR activation-dependent Crk binding to ZAP-70 might con-
tribute both to “outside-in” and “inside-out” signals that upreg-
ulate integrin-mediated T-cell adhesion. This model is partially
supported by findings from two independent studies, showing
that ZAP-70 with a Phe-to-Tyr substitution at position 315 abol-
ishes both CrkII binding to ZAP-70 (11) and TCR activation-
dependent increase in β1-integrin-mediated cell adhesion (71).
Further studies with Crk-SH2 mutants deficient in their abil-
ity to interact with ZAP-70 are needed in order to resolve this
issue.
As described earlier, one of the modes of regulation of CrkII
conformation and function involves its cis–trans isomerization
controlled by immunophilins (28, 29, 37). Our studies revealed
that a combination of immunophilin inhibitory drugs, which
includes CsA and FK506, interferes with C3G binding to CrkII
(14). This, in turn, impaired the integrin-associated signaling
and inhibited T-cell adhesion to fibronectin as well as migration
toward the chemokine, SDF-1α (14). We found that overex-
pression of either CrkI or CrkII increased T-cell adhesion and
invasion. However, inhibitors of immunophilin suppressed the
ability of CrkII-, but not CrkI-overexpressing Jurkat T cells
to adhere to fibronectin-coated surfaces and migrate toward
SDF-1α (14).
An additional effector molecule that regulates T-cell adhesion
by alteration of Crk-dependent signaling pathways is the E3-
ligase, Cbl (74). The Cbl protein catalyzes protein ubiquitination
and is involved in the regulation of TCR-coupled signals that
induce T-cell adhesion. Upon activation of T cells, Cbl under-
goes tyrosine phosphorylation and associates with the Crk-SH2
domain and p85, the regulatory subunit of the phosphoinositide
3-kinase (PI3-K), forming a trimolecular protein complex (74).
Cbl-b binding to CrkL induces the ubiquitination of CrkL, while
knockdown of Cbl-b results in an increase in several parameters
relevant to T-cell adhesion, including the association of CrkL and
C3G, activity of the small GTPase, Rap1, and clustering of LFA-1,
in response to TCR triggering (75, 76). The results suggest that
Cbl-b is a negative regulator of the CrkL-C3G-mediated Rap1
and LFA-1 activation of T cells and of Crk-regulated signaling
events that promote T-cell adhesion (75, 76). Protein complexes
consisting of Crk and Cbl are also involved in signaling from the
-selectin (CD62) adhesion receptors (77) as well as the CXCR4
chemokine receptor (78). Taken together, the results suggest that
Cbl-mediated regulation ofCrk-dependent signals is an important
element in the regulation of T-lymphocyte adhesion, migration,
and homing (79).
Concluding Remarks and Future
Directions
The Crk adaptor proteins play an essential role in the regulation of
T-cell adhesion and migration to sites of inflammation. Together
with C3G and CasL, they coordinate signaling pathways leading
to activation of Rap1 that upregulate the clustering and affinity
of integrins to their ligands. This general mechanism might be
relevant to the regulation of some, but not all, integrins since
different T-cell integrins might be coupled to distinct effector
proteins. The mechanism of regulation of the stoichiometric ratio
between CrkI, CrkII, and CrkL in specific cell types is unknown,
and the contribution of individual Crk isoforms to the adhesion
response has not been thoroughly studied. Further investigations
are also required in order to determine the potential regulation
of selected Crk proteins by isomerases and whether inhibitors
of immunophilins can downregulate T-cell adhesion and migra-
tion irrespective of their inhibition of the calcineurin/NFAT
pathway.
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